Chronic comorbidities in children and adolescents with type 1 diabetes

Soulmaz Fazelifarsani; Patrick C. Souverein; Marja M.J. Van Der Vorst; Catherijne A.J. Knibbe; Anthonius De Boer; Aukje K. Mantel-Teeuwisse

doi:10.1002/pds.3701

Abstract

Background: Limited quantitative data exist on the burden of chronic comorbidities in children and adolescents with type 1 diabetes (T1D). Such knowledge is necessary for the development of guidelines and prevention programs. Objectives: To determine the incidence of chronic comorbidities in children and adolescents with T1D and to compare the risks with the diabetes-free children. Methods: A population-based cohort study was conducted using the Dutch PHARMO-RLS that comprises community pharmacy dispensing records linked to hospital admissions. Insulin prescriptions were used as a proxy to identify incident cases of T1D. All patients (

Original language	English
Article number	351
Pages (from-to)	185
Number of pages	1
Journal	Pharmacoepidemiology and Drug Safety
Volume	23
Issue number	S1
DOIs	https://doi.org/10.1002/pds.3701
Publication status	Published - 1 Oct 2014

Bibliographical note

Special Issue: Abstracts of the 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, October 24–27, 2014, Taipei, Taiwan

Keywords

insulin
timonacic arginine
human
insulin dependent diabetes mellitus
pharmacoepidemiology
adolescent
risk management
child
diabetes mellitus
risk
prescription
hospital admission
diagnosis
patient
cohort analysis
ICD-9
enteritis
female
colitis
mental disease
thyroid disease
girl
population
confidence interval
hazard ratio
proportional hazards model
pharmacy
migraine
cardiovascular disease
epilepsy
lung disease
diseases
anemia
monitoring
prevention

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pds.3701

2Final published version, 80.1 KB

Cite this

@article{bd14b001ac9946a4b28b42d7da4e7687,

title = "Chronic comorbidities in children and adolescents with type 1 diabetes",

abstract = "Background: Limited quantitative data exist on the burden of chronic comorbidities in children and adolescents with type 1 diabetes (T1D). Such knowledge is necessary for the development of guidelines and prevention programs. Objectives: To determine the incidence of chronic comorbidities in children and adolescents with T1D and to compare the risks with the diabetes-free children. Methods: A population-based cohort study was conducted using the Dutch PHARMO-RLS that comprises community pharmacy dispensing records linked to hospital admissions. Insulin prescriptions were used as a proxy to identify incident cases of T1D. All patients (",

keywords = "insulin, timonacic arginine, human, insulin dependent diabetes mellitus, pharmacoepidemiology, adolescent, risk management, child, diabetes mellitus, risk, prescription, hospital admission, diagnosis, patient, cohort analysis, ICD-9, enteritis, female, colitis, mental disease, thyroid disease, girl, population, confidence interval, hazard ratio, proportional hazards model, pharmacy, migraine, cardiovascular disease, epilepsy, lung disease, diseases, anemia, monitoring, prevention",

author = "Soulmaz Fazelifarsani and Souverein, {Patrick C.} and {Van Der Vorst}, {Marja M.J.} and Knibbe, {Catherijne A.J.} and {De Boer}, Anthonius and Mantel-Teeuwisse, {Aukje K.}",

note = "Special Issue: Abstracts of the 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, October 24–27, 2014, Taipei, Taiwan",

year = "2014",

month = oct,

day = "1",

doi = "10.1002/pds.3701",

language = "English",

volume = "23",

pages = "185",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley and Sons Ltd",

number = "S1",

}

TY - JOUR

T1 - Chronic comorbidities in children and adolescents with type 1 diabetes

AU - Fazelifarsani, Soulmaz

AU - Souverein, Patrick C.

AU - Van Der Vorst, Marja M.J.

AU - Knibbe, Catherijne A.J.

AU - De Boer, Anthonius

AU - Mantel-Teeuwisse, Aukje K.

N1 - Special Issue: Abstracts of the 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, October 24–27, 2014, Taipei, Taiwan

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Background: Limited quantitative data exist on the burden of chronic comorbidities in children and adolescents with type 1 diabetes (T1D). Such knowledge is necessary for the development of guidelines and prevention programs. Objectives: To determine the incidence of chronic comorbidities in children and adolescents with T1D and to compare the risks with the diabetes-free children. Methods: A population-based cohort study was conducted using the Dutch PHARMO-RLS that comprises community pharmacy dispensing records linked to hospital admissions. Insulin prescriptions were used as a proxy to identify incident cases of T1D. All patients (

AB - Background: Limited quantitative data exist on the burden of chronic comorbidities in children and adolescents with type 1 diabetes (T1D). Such knowledge is necessary for the development of guidelines and prevention programs. Objectives: To determine the incidence of chronic comorbidities in children and adolescents with T1D and to compare the risks with the diabetes-free children. Methods: A population-based cohort study was conducted using the Dutch PHARMO-RLS that comprises community pharmacy dispensing records linked to hospital admissions. Insulin prescriptions were used as a proxy to identify incident cases of T1D. All patients (

KW - insulin

KW - timonacic arginine

KW - human

KW - insulin dependent diabetes mellitus

KW - pharmacoepidemiology

KW - adolescent

KW - risk management

KW - child

KW - diabetes mellitus

KW - risk

KW - prescription

KW - hospital admission

KW - diagnosis

KW - patient

KW - cohort analysis

KW - ICD-9

KW - enteritis

KW - female

KW - colitis

KW - mental disease

KW - thyroid disease

KW - girl

KW - population

KW - confidence interval

KW - hazard ratio

KW - proportional hazards model

KW - pharmacy

KW - migraine

KW - cardiovascular disease

KW - epilepsy

KW - lung disease

KW - diseases

KW - anemia

KW - monitoring

KW - prevention

U2 - 10.1002/pds.3701

DO - 10.1002/pds.3701

M3 - Meeting Abstract

SN - 1053-8569

VL - 23

SP - 185

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - S1

M1 - 351

ER -